Literature DB >> 5008196

Assessment of the biologic availability of tetracycline products in man.

W H Barr, L M Gerbracht, K Letcher, M Plaut, N Strahl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5008196     DOI: 10.1002/cpt197213197

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  15 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Bioavailability of commercial tetracycline products.

Authors:  D B Barnett; R N Smith; N D Greenwood; C Hetherington
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

3.  A history of biopharmaceutics in the Food and Drug Administration 1968-1993.

Authors:  Jerome Philip Skelly
Journal:  AAPS J       Date:  2009-11-20       Impact factor: 4.009

4.  Cross-over study of ten tetracycline preparations.

Authors:  J Tuomisto; P Männistö
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

5.  The bioavailability of sixteen tetracycline products.

Authors:  M C Meyer; R E Dann; P L Whyatt; G W Slywka
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

6.  Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.

Authors: 
Journal:  J Pharmacokinet Biopharm       Date:  1974-10

7.  Rapid, precise, turbidometric assay for low levels of ampicillin in serum after single-dose oral administration.

Authors:  P L Whyatt; R E Dann; G W Slywka; M C Meyer
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Trade names or approved names. Part III. Special cases. Antibiotics.

Authors:  L P Garrod
Journal:  Postgrad Med J       Date:  1974-02       Impact factor: 2.401

9.  Causes of failure in antibiotic treatment.

Authors:  L P Garrod
Journal:  Br Med J       Date:  1972-11-25

10.  Comparative bioavailability of three brands of ampicillin.

Authors:  C MacLeod; H Rabin; J Ruedy; M Caron; D Zarowny; R O Davies
Journal:  Can Med Assoc J       Date:  1972-08-05       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.